Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 131.265
2.39 %
$ 14 B
Market Cap
-182.31
P/E
ITCI - TOTAL ASSETS
Total Assets ITCI - Intra-Cellular Therapies, Inc.
728 M
LAST VALUE
21.92%
2 YEAR CAGR
15.31%
5 YEAR CAGR
34.20%
10 YEAR CAGR